Value of blood creatinine in children
Saraidarian B , David L , Nicolino M , Cochat P
Pediatrie 42 ( 5) 393
2
1987
[Somatomedins: growth and differentiation factors. Clinical implications].
Chatelain P , Nicolino M , De Parscau L , Saez J
Pediatrie 44 ( 4) 303 -308
1989
[Biosynthetic growth hormone: current therapeutic status and perspectives].
Chatelain P , Nicolino M , De Parscau L
Pediatrie 44 ( 3) 175
1989
Endocrine complications of treatment of brain tumors in children
Chatelain P , Nicolino M
Pédiatrie 46 ( 1) 109 -119
1991
[Intrauterine growth retardation, its consequences in infancy, in the child and long term].
Nicolino M , Claris O , Chatelain P , Salle Bl
Bulletin De L Academie Nationale De Medecine 185 ( 7) 1271
6
2001
Natural history of infantile-onset Pompe disease: results from a retrospective chart review study.
Deya Corzo , Hwu W , Mandel H , Nicolino M
Molecular Genetics and Metabolism 81 170 -170
3
2004
Adenovirus-Mediated Transfer of the Acid α-Glucosidase Gene into Fibroblasts, Myoblasts and Myotubes from Patients with Glycogen Storage Disease Type II Leads to High Level Expression of Enzyme and Corrects Glycogen Accumulation
M. P. Nicolino , J.-P. Puech , E. J. Kremer , A. J. J. Reuser
Human Molecular Genetics 7 ( 11) 1695 -1702
39
1998
OR27-03 Oral Infigratinib Treatment Is Well Tolerated And Significantly Increases Height Velocity In Children With Achondroplasia: Month 6 Results From The PROPEL 2 Dose-finding Study
Ravi Savarirayan , Josep Maria De Bergua , Paul Arundel , Jean Pierre Salles
Journal of the Endocrine Society 7 ( Supplement_1) bvad114. 1525 -bvad114. 1525
2
2023
THU181 Evaluation Of Bone Mineral Density In A Cohort Of Children With ACH Participating In The PROPEL 2 Study Of Infigratinib
Ravi Savarirayan , Josep Maria De Bergua , Paul Arundel , Jean Pierre Salles
Journal of the Endocrine Society 7 ( Supplement_1) bvad114. 1432 -bvad114. 1432
2023
THU165 PROPEL, PROPEL 2 And PROPEL OLE Studies Of Infigratinib In Children With Achondroplasia: Design And Status Of 3 Ongoing Trials
Ravi Savarirayan , Josep Maria De Bergua , Paul Arundel , Helen McDevitt
Journal of the Endocrine Society 7 ( Supplement_1) bvad114. 1416 -bvad114. 1416
2023
Mucocele of the sphenoid sinus
MP Nicolino , B LEBRIGAND , L Langevin , PG Chatelain
Archives of pediatrics & adolescent medicine 151 ( 1) 93 -94
2
1997
Diabétologie de l'enfant
Régis Coutant , Marc NICOLINO
Elsevier Health Sciences
1
2019
A familial form of DSD due to NR5A1 mutation in a father and his son
Claire-Lise Gaya , Daniela Gorduzad , Aude Brac de la Perriereb , Ingrid Plottonc
HORMONE RESEARCH IN PAEDIATRICS 86 276 -276
2016
New insights into the postnatal growth of infants born 'idiopathic' small for gestational age.
Georges Mellier , Alexandre Lapillonne , Marc Nicolino , Olivier Claris
Journal of Pediatric Endocrinology and Metabolism 14 1515 -1519
1
2001
Acylated and Unacylated Ghrelin Levels in Children and Young Adults with Prader-Willi Syndrome
Delphine Bernoux , Soraya Allas , Catherine Molinas , Gwenaelle Diene
ESPE 2014
2014
[Clinical development of acid alpha-glucosidase for the treatment of Pompe disease].
Marc Nicolino
Presse Medicale
2007
WHAT IS THE RISK FOR CHILDHOOD OBESITY
Cahine Villanueva , Marc Nicolino
La Revue du praticien 65 ( 10) 1275 -1277
2015
From paediatric to adult endocrinology care: the challenge of the transition period.
Marc Nicolino , Michel Pugeat
Pediatric endocrinology reviews 519 -522
7
2009
Retard de croissance intra-utérin, ses conséquences dans l'enfance et à long terme
Olivier Claris , Pierre Chatelain , Bernard-Louis Salle , Marc Nicolino
Médecine & enfance 23 3 -5
2003
L’alglucosidase alpha, premier traitement pour la maladie de Pompe
Marc Nicolino
Presse Medicale 36
2007